MAPT and early-onset autosomal dominant Alzheimer disease: CeNCs exhibited high ROS activity and antioxidant properties in mitochondrial oxidative-stress-induced damage therapy in Alzheimer’s disease, acting as tau hyperphosphorylation inhibitors.